This bill mandates that all group and individual health insurance policies, including self-insured plans, health maintenance organization contracts, and nonprofit health care plans, provide coverage for at least one injectable glucagon-like peptide-1 receptor agonist prescribed for chronic weight management in adults with obesity. The new legal language specifies that this requirement applies to any health coverage that includes prescription drugs and is delivered, issued for delivery, or renewed in the state of New Mexico.

The provisions of the bill will take effect for all applicable health insurance policies, plans, and contracts starting January 1, 2026. This legislation aims to enhance access to weight loss medications for individuals struggling with obesity, thereby promoting better health outcomes within the population.